- Report
- December 2023
- 117 Pages
Asia Pacific
From €1439EUR$1,500USD£1,240GBP
- Report
- August 2021
- 274 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- February 2022
- 120 Pages
Global
From €2399EUR$2,500USD£2,066GBP
The Waterborne Disease market within the context of Infectious Disease Testing is focused on the detection and diagnosis of waterborne pathogens. These pathogens can be found in contaminated water sources, such as rivers, lakes, and oceans, and can cause a variety of illnesses, including gastrointestinal, respiratory, and skin infections. Testing for waterborne diseases is important for public health, as it can help identify and prevent outbreaks.
Testing for waterborne diseases typically involves the use of molecular techniques, such as PCR and ELISA, as well as traditional culture-based methods. These tests can detect a wide range of pathogens, including bacteria, viruses, and parasites.
The Waterborne Disease market is highly competitive, with a number of companies offering testing services. These include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Luminex Corporation. Show Less Read more